A randomized phase II trial of mirvetuximab soravtansine (IMGN853), in folate receptor alpha (FRa)-high recurrent ovarian cancer eligible for platinum-based chemotherapy.
Mirvetuximab Soravtansine
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A randomized phase II trial of mirvetuximab soravtansine (IMGN853), in folate receptor alpha (FRa)-high recurrent ovarian cancer eligible for platinum-based chemotherapy. ### Output: Mirvetuximab Soravtansine